Linical Co., Ltd. (2183.T)
JPY 294.0
(2.8%)
JPY 294.0
(2.8%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.53 Billion JPY | 6.16% |
| 2022 | 17.46 Billion JPY | 11.12% |
| 2021 | 15.71 Billion JPY | 2.85% |
| 2020 | 15.28 Billion JPY | 7.15% |
| 2019 | 14.26 Billion JPY | 7.56% |
| 2018 | 13.25 Billion JPY | 43.38% |
| 2017 | 9.24 Billion JPY | 11.41% |
| 2016 | 8.3 Billion JPY | 16.54% |
| 2015 | 7.12 Billion JPY | 26.23% |
| 2014 | 5.64 Billion JPY | 98.92% |
| 2013 | 2.83 Billion JPY | 7.34% |
| 2012 | 2.64 Billion JPY | 22.63% |
| 2011 | 2.15 Billion JPY | 38.04% |
| 2010 | 1.56 Billion JPY | 10.95% |
| 2009 | 1.4 Billion JPY | 12.03% |
| 2008 | 1.25 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 18.98 Billion JPY | 2.4% |
| 2023 Q2 | 18.21 Billion JPY | 3.12% |
| 2023 FY | 18.53 Billion JPY | 6.16% |
| 2023 Q4 | 18.53 Billion JPY | 4.86% |
| 2023 Q3 | 17.68 Billion JPY | -2.91% |
| 2023 Q1 | 17.66 Billion JPY | 1.12% |
| 2022 Q1 | 16.32 Billion JPY | 3.89% |
| 2022 Q2 | 17.26 Billion JPY | 5.74% |
| 2022 Q3 | 16.84 Billion JPY | -2.42% |
| 2022 Q4 | 17.46 Billion JPY | 3.66% |
| 2022 FY | 17.46 Billion JPY | 11.12% |
| 2021 Q2 | 14.38 Billion JPY | -1.31% |
| 2021 Q1 | 14.57 Billion JPY | -4.59% |
| 2021 Q3 | 15.33 Billion JPY | 6.59% |
| 2021 Q4 | 15.71 Billion JPY | 2.48% |
| 2021 FY | 15.71 Billion JPY | 2.85% |
| 2020 FY | 15.28 Billion JPY | 7.15% |
| 2020 Q2 | 13.86 Billion JPY | -3.78% |
| 2020 Q1 | 14.4 Billion JPY | 1.02% |
| 2020 Q3 | 14.24 Billion JPY | 2.75% |
| 2020 Q4 | 15.28 Billion JPY | 7.28% |
| 2019 FY | 14.26 Billion JPY | 7.56% |
| 2019 Q4 | 14.26 Billion JPY | 1.08% |
| 2019 Q1 | 13.66 Billion JPY | 3.1% |
| 2019 Q3 | 14.1 Billion JPY | 3.65% |
| 2019 Q2 | 13.61 Billion JPY | -0.42% |
| 2018 Q1 | 13.76 Billion JPY | 48.83% |
| 2018 FY | 13.25 Billion JPY | 43.38% |
| 2018 Q4 | 13.25 Billion JPY | -1.1% |
| 2018 Q3 | 13.4 Billion JPY | -5.52% |
| 2018 Q2 | 14.18 Billion JPY | 3.1% |
| 2017 Q4 | 9.24 Billion JPY | 0.81% |
| 2017 Q1 | 8.31 Billion JPY | 0.22% |
| 2017 FY | 9.24 Billion JPY | 11.41% |
| 2017 Q2 | 8.48 Billion JPY | 2.04% |
| 2017 Q3 | 9.17 Billion JPY | 8.06% |
| 2016 Q4 | 8.3 Billion JPY | 9.03% |
| 2016 Q1 | 6.75 Billion JPY | -5.21% |
| 2016 FY | 8.3 Billion JPY | 16.54% |
| 2016 Q2 | 6.98 Billion JPY | 3.44% |
| 2016 Q3 | 7.61 Billion JPY | 9.01% |
| 2015 Q2 | 6.87 Billion JPY | 10.49% |
| 2015 Q4 | 7.12 Billion JPY | -0.38% |
| 2015 Q1 | 6.22 Billion JPY | 10.35% |
| 2015 FY | 7.12 Billion JPY | 26.23% |
| 2015 Q3 | 7.14 Billion JPY | 3.93% |
| 2014 FY | 5.64 Billion JPY | 98.92% |
| 2014 Q1 | 2.85 Billion JPY | 0.52% |
| 2014 Q4 | 5.64 Billion JPY | 4.11% |
| 2014 Q3 | 5.41 Billion JPY | 85.12% |
| 2014 Q2 | 2.92 Billion JPY | 2.69% |
| 2013 Q3 | 2.64 Billion JPY | 7.96% |
| 2013 Q4 | 2.83 Billion JPY | 7.08% |
| 2013 FY | 2.83 Billion JPY | 7.34% |
| 2013 Q1 | 2.5 Billion JPY | -5.2% |
| 2013 Q2 | 2.45 Billion JPY | -2.06% |
| 2012 Q1 | 2.21 Billion JPY | 2.6% |
| 2012 Q2 | 2.23 Billion JPY | 1.21% |
| 2012 Q3 | 2.37 Billion JPY | 6.3% |
| 2012 Q4 | 2.64 Billion JPY | 11.1% |
| 2012 FY | 2.64 Billion JPY | 22.63% |
| 2011 Q1 | 1.5 Billion JPY | -3.3% |
| 2011 FY | 2.15 Billion JPY | 38.04% |
| 2011 Q2 | 1.65 Billion JPY | 9.63% |
| 2011 Q3 | 1.85 Billion JPY | 12.29% |
| 2011 Q4 | 2.15 Billion JPY | 15.94% |
| 2010 Q3 | 1.58 Billion JPY | 13.66% |
| 2010 Q4 | 1.56 Billion JPY | -1.3% |
| 2010 FY | 1.56 Billion JPY | 10.95% |
| 2010 Q2 | 1.39 Billion JPY | 0.0% |
| 2009 Q1 | 1.35 Billion JPY | 7.55% |
| 2009 FY | 1.4 Billion JPY | 12.03% |
| 2009 Q4 | 1.4 Billion JPY | 7.92% |
| 2009 Q3 | 1.3 Billion JPY | -7.43% |
| 2009 Q2 | 1.4 Billion JPY | 4.28% |
| 2008 Q4 | 1.25 Billion JPY | 0.0% |
| 2008 FY | 1.25 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | -181.363% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -1430.421% |
| GNI Group Ltd. | 62.39 Billion JPY | 70.286% |
| Trans Genic Inc. | 9.81 Billion JPY | -88.971% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -229.064% |
| Soiken Holdings Inc. | 6.94 Billion JPY | -166.91% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -218.756% |
| AnGes, Inc. | 28.89 Billion JPY | 35.831% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -2037.72% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 88.206% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -1045.442% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -265.587% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -326.216% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -662.064% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -681.164% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | -167.521% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -958.544% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -264.561% |
| PeptiDream Inc. | 67.12 Billion JPY | 72.381% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -808.553% |
| Ribomic Inc. | 3.54 Billion JPY | -422.655% |
| SanBio Company Limited | 5.04 Billion JPY | -267.324% |
| Healios K.K. | 15.15 Billion JPY | -22.335% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -1406.995% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -514.719% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -1157.664% |
| StemRIM | 9.08 Billion JPY | -104.184% |
| CellSource Co., Ltd. | 6.87 Billion JPY | -169.486% |
| FunPep Company Limited | 2.49 Billion JPY | -644.236% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -607.993% |
| Stella Pharma Corporation | 3.82 Billion JPY | -385.259% |
| TMS Co., Ltd. | 3.55 Billion JPY | -421.553% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -220.818% |
| Cuorips Inc. | 6.18 Billion JPY | -199.769% |
| K Pharma,Inc. | 3.31 Billion JPY | -459.459% |
| Takara Bio Inc. | 123.2 Billion JPY | 84.952% |
| ReproCELL Incorporated | 9.05 Billion JPY | -104.801% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -582.789% |
| StemCell Institute Inc. | 6.54 Billion JPY | -183.352% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | -165.281% |
| CellSeed Inc. | 2.46 Billion JPY | -651.892% |